LYDIA ALBUQUERQUE: Open Payments
NPI 1497014989 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 15 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $128 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $159 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Stryker Corporation | 1 | $39 |
| Abbott Laboratories | 1 | $34 |
| ABIOMED | 1 | $29 |
| Imperative Care, Inc | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Barostim Neo System, WAINUA, ARTIX MT, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, SYMPHONY CATHETER, Kerendia, AMVUTTRA, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
